JP2008522630A5 - - Google Patents

Download PDF

Info

Publication number
JP2008522630A5
JP2008522630A5 JP2007545722A JP2007545722A JP2008522630A5 JP 2008522630 A5 JP2008522630 A5 JP 2008522630A5 JP 2007545722 A JP2007545722 A JP 2007545722A JP 2007545722 A JP2007545722 A JP 2007545722A JP 2008522630 A5 JP2008522630 A5 JP 2008522630A5
Authority
JP
Japan
Prior art keywords
cell line
recombinant adenovirus
deposited
name
accession number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007545722A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008522630A (ja
JP4621743B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/045097 external-priority patent/WO2006065827A2/en
Publication of JP2008522630A publication Critical patent/JP2008522630A/ja
Publication of JP2008522630A5 publication Critical patent/JP2008522630A5/ja
Application granted granted Critical
Publication of JP4621743B2 publication Critical patent/JP4621743B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007545722A 2004-12-13 2005-12-12 複製欠損アデノウイルスの産生のための細胞株 Expired - Fee Related JP4621743B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63556104P 2004-12-13 2004-12-13
US67448805P 2005-04-25 2005-04-25
PCT/US2005/045097 WO2006065827A2 (en) 2004-12-13 2005-12-12 Cell lines for production of replication-defective adenovirus

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2010199416A Division JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Publications (3)

Publication Number Publication Date
JP2008522630A JP2008522630A (ja) 2008-07-03
JP2008522630A5 true JP2008522630A5 (enExample) 2010-10-21
JP4621743B2 JP4621743B2 (ja) 2011-01-26

Family

ID=36282846

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2007545722A Expired - Fee Related JP4621743B2 (ja) 2004-12-13 2005-12-12 複製欠損アデノウイルスの産生のための細胞株
JP2010199416A Withdrawn JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010199416A Withdrawn JP2011015696A (ja) 2004-12-13 2010-09-06 複製欠損アデノウイルスの産生のための細胞株

Country Status (8)

Country Link
US (1) US7851218B2 (enExample)
EP (1) EP1831352B1 (enExample)
JP (2) JP4621743B2 (enExample)
CN (1) CN101208425B (enExample)
AT (1) ATE516343T1 (enExample)
CA (1) CA2590943C (enExample)
MX (1) MX2007007145A (enExample)
WO (1) WO2006065827A2 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1655827B (zh) 2002-05-27 2010-06-23 佩尔·松内·霍尔姆 腺病毒和编码其的核酸的新应用
WO2005051430A1 (de) 2003-11-14 2005-06-09 Per Sonne Holm Neue verwendung von adenoviren und dafür codierenden nukleinsäuren
JP4621743B2 (ja) 2004-12-13 2011-01-26 カンジ，インコーポレイテッド 複製欠損アデノウイルスの産生のための細胞株
EP1830864A2 (de) * 2004-12-31 2007-09-12 Per Sonne Holm E1 -minus adenoviren und deren verwendung
US20070249043A1 (en) 2005-12-12 2007-10-25 Mayall Timothy P Adenoviral expression vectors
US9913832B2 (en) * 2009-10-12 2018-03-13 Rajabrata Sarkar Accelerating thrombus resolution through augmentation of p53 activity
CN103987726B (zh) 2011-10-05 2017-10-03 金维克有限公司 猴(大猩猩)腺病毒或腺病毒载体及其使用方法
JP6757120B2 (ja) 2011-10-05 2020-09-16 ジェンヴェック エルエルシー アーフェンアデノウイルス（ゴリラ）又はアデノウイルスベクター、及び使用方法
IN2014DN03005A (enExample) 2011-10-05 2015-05-08 Genvec Inc
KR101427200B1 (ko) * 2011-11-24 2014-08-07 주식회사 바이로메드 아데노바이러스 생산 신규 세포주 및 그의 용도
US9676824B2 (en) 2012-05-29 2017-06-13 Genvec, Inc. Herpes simplex virus vaccine
JP2016519108A (ja) 2013-04-18 2016-06-30 アルモ・バイオサイエンシーズ・インコーポレイテッド インターロイキン−１０を疾病及び疾患の治療に用いる方法
EP3341012B1 (en) 2015-08-25 2025-07-30 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
CN110832072B (zh) * 2017-04-21 2023-11-07 真基因太科公司 用于生产非复制型腺病毒的细胞系以及制备所述细胞系的方法
AU2018300000B2 (en) * 2017-07-10 2021-11-11 Gen-Probe Incorporated Analytical systems and methods for nucleic acid amplification using sample assigning parameters
EP3906038A4 (en) 2018-11-21 2022-06-01 Mayo Foundation for Medical Education and Research ADENOVIRUS AND METHODS OF USE OF ADENOVIRUS
WO2021136347A1 (zh) * 2019-12-30 2021-07-08 南京金斯瑞生物科技有限公司 一种哺乳动物表达系统使用的高表达载体
AU2021251718A1 (en) 2020-04-07 2022-11-10 Lung Biotechnology Pbc Adenoviral expression vector and methods and cell lines for production
CN113736780B (zh) * 2020-05-28 2024-05-28 暨南大学 一种敲除p300基因的BCBL1细胞系及其构建方法与应用
CN114262691A (zh) * 2020-09-16 2022-04-01 杭州康万达医药科技有限公司 分离的能够用于表达外源基因的溶瘤腺病毒、载体、治疗剂及其用途
CN112156181A (zh) * 2020-09-29 2021-01-01 广州恩宝生物医药科技有限公司 一种腺病毒四价疫苗
CN117264902A (zh) * 2022-06-15 2023-12-22 上海元宋生物技术有限公司 一种腺病毒包装与生产细胞系的构建方法及应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6835557B1 (en) 1980-01-08 2004-12-28 Biogen, Inc. DNA sequences, recombinant DNA molecules and processes for producing human interferon-like polypeptides
US6210939B1 (en) 1993-10-25 2001-04-03 Canji, Inc. Recombinant adenoviral vector and methods of use
TW442569B (en) 1993-10-25 2001-06-23 Canji Inc Recombinant adenoviral vector
US5837520A (en) 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
EP1445322B2 (en) 1995-06-15 2012-06-06 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US6392069B2 (en) 1996-01-08 2002-05-21 Canji, Inc. Compositions for enhancing delivery of nucleic acids to cells
US5789244A (en) 1996-01-08 1998-08-04 Canji, Inc. Compositions and methods for the treatment of cancer using recombinant viral vector delivery systems
US5891690A (en) 1996-04-26 1999-04-06 Massie; Bernard Adenovirus E1-complementing cell lines
US6248514B1 (en) 1996-07-09 2001-06-19 Canji, Inc. Methods for measuring viral infectivity
US6261823B1 (en) 1996-12-13 2001-07-17 Schering Corporation Methods for purifying viruses
US6544769B1 (en) 1996-12-13 2003-04-08 Schering Corporation Compostions comprising viruses and methods for concentrating virus preparations
US6146891A (en) 1997-01-31 2000-11-14 Schering Corporation Methods for cultivating cells and propagating viruses
CA2723040A1 (en) 1998-02-17 1999-08-19 Schering Corporation Compositions comprising viruses and methods for concentrating virus preparations
US6670188B1 (en) * 1998-04-24 2003-12-30 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US5994134A (en) 1998-05-04 1999-11-30 Canji, Inc. Viral production process
US7691370B2 (en) * 1998-10-15 2010-04-06 Canji, Inc. Selectivity replicating viral vector
US7001770B1 (en) 1998-10-15 2006-02-21 Canji, Inc. Calpain inhibitors and their applications
US6649158B1 (en) * 1998-10-15 2003-11-18 Canji, Inc. Methods and compositions to induce antitumor response
US6430595B1 (en) 1999-05-20 2002-08-06 Cisco Technology, Inc. Method and apparatus for establishing a database used for correlating information gathered via SNMP
US20020064860A1 (en) 2000-11-29 2002-05-30 Schering Corporation Method for purifying adenoviruses
KR20060012661A (ko) 2003-06-04 2006-02-08 캔지, 인크. 인터페론 요법을 위한 방법 및 조성물
US7026164B2 (en) * 2003-07-03 2006-04-11 Cell Genesys, Inc. Adenovirus packaging cell lines
CA2548100C (en) 2003-12-10 2015-03-24 Canji, Inc. Methods and compositions for treatment of interferon-resistant tumors
JP4621743B2 (ja) 2004-12-13 2011-01-26 カンジ，インコーポレイテッド 複製欠損アデノウイルスの産生のための細胞株
CN101384893A (zh) 2006-02-10 2009-03-11 柏林自由大学 用于制备生物样品的方法和装置

Similar Documents

Publication Publication Date Title
JP2008522630A5 (enExample)
JP2020022459A5 (enExample)
JP2010531148A5 (enExample)
NZ601424A (en) Method for the production of ad26 adenoviral vectors
JP2010273685A5 (enExample)
JP2006115849A5 (enExample)
JP2008245635A5 (enExample)
WO2010138263A3 (en) Novel aav 's and uses thereof
AU2014203512B2 (en) Recombinant virus-like particles encoded by multi-gene vector
CN108603176A (zh) 无病毒细胞系及获得其的方法
WO2009116861A3 (en) Diagnostic of pre-symptomatic metabolic syndrome
WO2004094466A3 (en) Recombinant influenza viruses holding a mutation in a transmembrane protein gene
KR102160486B1 (ko) 돼지생식기호흡기증후군(prrs) 바이러스 유전형 판별용 pna 프로브 및 이를 이용한 돼지생식기호흡기증후군(prrs) 유전형 판별방법
JP2012531205A5 (enExample)
JP2011500592A5 (enExample)
JP2007075118A5 (enExample)
ATE555196T1 (de) Wärmebeständige duplexspezifische nuklease
JP2009523007A5 (enExample)
EP2383343A3 (en) Recombinant varicella-zoster virus
WO2007082734A3 (en) Influenza vaccine
IL179911A0 (en) Methods related to a single nucleotide polymorphism of the g protein coupled receptor, gpr40
CN101255477B (zh) 栉孔扇贝g-型溶菌酶基因多态性标记筛选及其辅助育种方法
JP2006507816A5 (enExample)
EP2434018A3 (en) A novel beta-galactoside-alpha2, 3-sialyltransferase, a gene encoding thereof, and a method for producing thereof
CA2624544A1 (en) Vero cell line adapted to grow in suspension